publication venue for
- Case study: risk associated to wearing silver or graphene nanoparticlecoated facemasks for protection against COVID-19. 105-109. 2022
- Case study: risk associated to wearing silver or graphene nanoparticle-coated facemasks for protection against COVID-19 2021
- Case study: Is bisphenol S safer than bisphenol A in thermal papers? 2019
- Interactions of human butyrylcholinesterase with phenylvalerate and acetylthiocholine as substrates and inhibitors: kinetic and molecular modeling approaches. 1281-1296. 2019
- Phenyl valerate esterase activity of human butyrylcholinesterase. 3295-3305. 2017
- Butyrylcholinesterase identification in a phenylvalerate esterase¿enriched fraction sensitive to low mipafox concentrations in chicken brain 2016
- Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches. 1-14. 2015
- Stereospecific hydrolysis of a phosphoramidate used as an OPIDP model by human sera with PON1 192 alloforms 2014
- Kinetic interactions of a neuropathy potentiator (phenylmethylsulfonyl fluoride) with the neuropathy target esterase and other membrane bound esterases. 1-12. 2013
- Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity. 767-777. 2012
- Expression of Neuropathy Target Esterase (NTE) in mouse embryonic stem cells during differentiation. 481-491. 2010
- An in vitro approach for demonstrating the critical role of serum albumin in the detoxication of the carbamate carbaryl at in vivo toxicologically relevant concetrations. 113-119. 2007
- Comparative hydrolysis of O-hexyl O-2,5-dichlorophenyl phosphoramidate and paraoxon in different tissues of vertebrates. 689-695. 2007
- Hydrolysis of carbaryl by human serum albumin. 629-634. 2004